The Effect of Thyrotoxicosis on Adrenocortical Reserve
Overview
Affiliations
Objective: Variations in thyroid function are known to be associated with changes in adrenocortical activity. Previous studies in animals have suggested that long-standing hyperthyroidism may be associated with diminished adrenal functional reserve despite a continuing hyperactivity of the hypothalamic-pituitary-adrenal (HPA) axis. In humans, there has been no direct assessment of adrenal secretory reserve in clinical thyrotoxicosis. This study aimed to assess adrenocortical reserve in response to low-dose ACTH, following dexamethasone suppression, in patients with severe thyrotoxicosis.
Design And Methods: Ten patients (four men and six women, 30-45 years) with severe long-standing thyrotoxicosis due to Graves' disease (n=6) or toxic nodular goitre (n=4) were studied at diagnosis and again when in a stable euthyroid state following drug therapy for 8-12 months. All patients underwent ACTH stimulation tests at 0800h with ACTH(1-24) (Cortrosyn; 0.1microg/kg body weight, i.v.) following overnight suppression of the HPA axis with dexamethasone (1mg per os at 2300h). Serum cortisol was assayed at -15, 0, 15, 30, 60 and 90min after the administration of ACTH.
Results: The mean (+/-s.d.) peak and delta cortisol responses to ACTH (634.5+/-164nmol/l and 618+/- 196nmol/l respectively), as well as the net area under the response curve (36769+/-12188nmol/lx min) in the hyperthyroid patients were significantly lower compared with the values when the same patients were euthyroid (911+/-157nmol/l, 905+/-160nmol/l and 57652+/-10128nmol/lxmin respectively; P<0.005). Subnormal peak cortisol responses (<500nmol/l) were observed in two severely toxic patients. The findings were independent of the cause of thyrotoxicosis.
Conclusion: In patients with severe thyrotoxicosis, cortisol secretion in response to low-dose ACTH stimulation, following dexamethasone suppression, is lower in the hyperthyroid than in the euthyroid state. It appears that thyrotoxicosis is associated with subtle impairment of adrenocortical reserve.
Long-term survival in a dog with probable thyroid storm.
Beverly J, Pigott A, Puzio C, Rivera M Clin Case Rep. 2023; 11(6):e7437.
PMID: 37266347 PMC: 10229745. DOI: 10.1002/ccr3.7437.
Graves' disease as a driver of depression: a mechanistic insight.
Song Y, Wang X, Ma W, Yang Y, Yan S, Sun J Front Endocrinol (Lausanne). 2023; 14:1162445.
PMID: 37152963 PMC: 10157224. DOI: 10.3389/fendo.2023.1162445.
Stress-Related Immune Response and Selenium Status in Autoimmune Thyroid Disease Patients.
Vaivode I, Zake T, Strele I, Upmale-Engela S, Gogins D, Gersone G Int J Mol Sci. 2023; 24(3).
PMID: 36768762 PMC: 9917185. DOI: 10.3390/ijms24032440.
A case report of new onset graves' disease induced by SARS-CoV-2 infection or vaccine?.
Hamouche W, El Soufi Y, Alzaraq S, Okafor B, Zhang F, Paras C J Clin Transl Endocrinol Case Rep. 2021; 23:100104.
PMID: 34934633 PMC: 8679515. DOI: 10.1016/j.jecr.2021.100104.
Zhao H, Ruan Y Int J Gen Med. 2021; 14:1641-1646.
PMID: 33976564 PMC: 8104983. DOI: 10.2147/IJGM.S305454.